Agios Pharmaceuticals, Inc. (AGIO)

Last Closing Price: 27.60 (2026-11-20)

Stock-Based Compensation (Quarterly)

Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.

Agios Pharmaceuticals, Inc. (AGIO) had Stock-Based Compensation of $48.15M for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
$55.38M
$-65.05M
$2.52M
$52.86M
$132.54M
$-77.16M
$12.12M
$-65.05M
$-65.05M
$-65.05M
$-65.05M
$-65.05M
$-65.05M
$-77.16M
$-76.63M
59.71M
59.71M
$-1.09
$-1.09
Balance Sheet Financials
$752.10M
$10.36M
$311.94M
$1.06B
$77.59M
--
$7.12M
$84.70M
$979.34M
$979.34M
$979.34M
59.78M
Cash Flow Statement Financials
$-235.47M
$265.48M
$9.41M
$89.13M
$128.55M
$39.42M
Stock-Based Compensation
$48.15M
--
--
Fundamental Metrics & Ratios
9.69
--
--
--
--
95.44%
-139.32%
-139.32%
--
-117.44%
-117.44%
$-238.63M
--
--
--
0.05
0.07
2.19
41.04
-6.64%
-6.64%
-6.11%
-6.64%
$16.38
$-4.00
$-3.94